Neutralizing IL-7 promotes long-term allograft survival induced by CD40/CD40L costimulatory blockade

American Journal of Transplantation

Volumn 6, Issue 12, 2006, Pages 2851-2860

  Wang, Y ^a,b   Dai, H ^a   Liu, Z ^a   Cheng, X ^a   Tellides, G ^b   Dai, Z ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allograft survival; Growth factor; Memory T cells

Indexed keywords

CD40 LIGAND; INTERLEUKIN 2; INTERLEUKIN 7;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOSUPPRESSIVE TREATMENT; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SURVIVAL TIME;

ANIMALS; ANTIGENS, CD40; CD40 LIGAND; CELL DIVISION; DENDRITIC CELLS; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; INTERLEUKIN-7; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; NEUTRALIZATION TESTS; PEPTIDYL-DIPEPTIDASE A; SKIN TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 33751191378     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01550.x     Document Type: Article

References (51)

1. Zhai Y, Meng L, Gao F, Busuttil RW, Kupiec-Weglinski JW. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: Therapeutic implications for sensitized transplant recipients. J Immunol 2002; 169: 4667-4673.
2. Trambley J, Bingaman AW, Lin A et al. Asialo GM1+CD8+ T cells play a critical role in costimulation blockade-resistant allograft rejection. J. Clin Invest 1999; 104: 1715-1722.
3. Chen Y, Heeger PS, Valujskikh A. In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy. J Immunol 2004; 172: 5456-5466.
4. Dai Z, Li Q, Wang Y et al. CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism. J Clin Invest 2004; 113: 310-317.
5. Heeger PS, Greenspan NS, Kuhlenschmidt S et al. Pretransplant frequency of donor-specific, IFN-γ -producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection epidodes. J Immunol 1999; 163: 2267-2275.
6. Wu Z, Bensinger SJ, Zhang J et al. Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med 2004; 10: 87-92.
7. Lakkis FG Sayegh MH. Memory T cells: A hurdle to immunologic tolerance. J Am Soc Nephrol 2003; 14: 2402-2410.
8. Nasr IW, Wang Y, Gao G et al. Testicular immune privilege promotes transplantation tolerance by altering the balance between memory and regulatory T cells. J Immunol 2005; 174: 6161-6168.
9. Jones ND, Carvalho-Gaspar M, Luo S, Brook MO, Martin L, Wood KJ. Effector and memory CD8+ T cells can be generated in response to alloantigen independently of CD4+ T cell help. J Immunol 2006; 176: 2316-2323.
10. Zhang Y, Joe G, Hexner E, Zhu J, Emerson SG. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease. J Immunol 2005; 174: 3051-3058.
11. Kieper WC, Tan JT, Bondi-boyd B et al. Overexpression of interleukin-7 leads to IL-15-independent generation of memory phenotype CD8+ T cells. J Exp Med 2002; 195: 1533-1539.
12. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 2000; 1: 426-432.
13. Li J, Huston G, Swain SL. IL-7 promotes the transition of CD4 effectors to persistant memory cells. J Exp Med 2003; 198: 1807-1815.
14. Kondrack RM, Harbertson J, Tan JT, McBreen ME, Surh CD, Bradley LM. Interleukin-7 regulates the survival and generation of memory CD4 cells. J Exp Med 2003; 198: 1797-1806.
15. Lin H, Bolling SF, Linsley PS et al. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med 1993; 178: 1801-1806.
16. Markees TG, Phillips NE, Gordon EJ et al. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4+ T cells, interferonc γ, and CTLA4. J Clin Invest 1998; 101: 2446-2455.
17. Sandner SE, Clarkson MR, Salama AD et al. Mechanisms of tolerance induced by donor-specific transfusion and ICOS-B7h blockade in a model of CD4+ T-cell-mediated allograft rejection. Am J Transplant 2005; 5: 31-39.
18. Zheng XX, Markees TG, Hancock WW et al. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment. J Immunol 1999; 162: 4983-4990.
19. Ozkaynak E, Gao W, Shemmeri N et al. Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat Immunol 2001; 2: 591-596.
20. Larsen C, Elwood E, Alexander D et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434-438.
21. Wells AD, Li XC, Li Y et al. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med 1999; 5: 1303-1307.
22. Quezada SA, Bennett K, Blazar BR, Rudensky AY, Sakaguchi S, Noelle RJ. Analysis of the underlying cellular mechanisms of anti-CD154-induced graft tolerance: The interplay of clonal anergy and immune regulation. J Immunol 2005; 175: 771-779.
23. Lee I, Wang L, Wells AD, Dorf ME, Ozkaynak E, Hancock WW. Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med 2005; 201: 1037-1044.
24. Banuelos SJ, Markees TG, Phillips NE et al. Regulation of skin and islet allograft survival in mice treated with costimulation blockade is mediated by different CD4+ cell subsets and different mechanisms. Transplantation 2004; 78: 660-667.
25. Kataoka M, Margenthaler JA, Ku G, Flye MW. Development of infectious tolerance after donor-specific transfusion and rat heart transplantation. J Immunol 2003; 171: 204-211.
26. Iwakoshi NN, Mordes JP, Markees TG, Phillips NE, Rossini AA, Greiner DL. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner. J Immunol 2000; 164: 512-521.
27. Gordon EJ, Woda BA, Shultz LD, Rossini AA, Greiner DL, Mordes JP. Rat xenograft survival in mice treated with donor-specific transfusion and anti-CD154 antibody is enhanced by elimination of host CD4+ cells. Transplantation 2001; 71: 319-327.
28. Margenthaler JA, Kataoka M, Flye MW. Donor-specific antigen transfusion-mediated skin graft tolerance results from the peripheral deletion of donor-reactive CD8+ T cells. Transplantation 2003; 75: 2119-2127.
29. Dai Z, Konieczny BT, Baddoura FK, Lakkis FG. Impaired alloantigen-mediated T cell apoptosis and failure to induce long term allograft survival in interleukin-2-deficient mice. J Immunol 1998; 161: 1659-1663.
30. Chalasani G, Dai Z, Konieczny B, Baddoura FK, Lakkis FG. Recall and propagation of allospecific memory T cells independent of secondary lymphoid organs. Proc Natl Acad Sci USA 2002; 99: 6175-6180.
31. Dai Z, Nasr IW, Reel M et al. Impaired recall of CD8 memory T cells in an immunologically-privileged tissue. J Immunol 2005; 174: 1165-1170.
32. Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001; 291: 2413-2417.
33. Northrop JK, Thomas RM, Wells AD, Shen H. Epigenetic remodeling of the IL-2 and IFN-γ loci in memory CD8 T cells is influenced by CD4 T cells. J Immunol 2006; 177: 1062-1069.
34. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. Selective expression of the interleukin-7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 2003; 4: 1191-1198.
35. Mackall CL, Fry TJ, Bare C, Morgan P, Galbraith A, Gress RE. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 2001; 97: 1491-1497.
36. Sinha ML, Fry TJ, Fowler DH, Miller G, Mackall CL. Interleukin-7 worsens graft-versus-host disease. Blood 2002; 100: 2642-2649.
37. Alpdogan O, Muriglan SJ, Eng JM et al. IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation. J Clin Invest 2003; 112: 1095-1107.
38. Gendelman M, Hecht T, Logan B, Vodanovic-Jankovic S, Komorowski R, Drobyski WR. Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease. J Immunol 2004; 172: 3328-3336.
39. Broers AEC, Posthumus-van Sluijs SJ, Spits H et al. Interleukin-7 improves T-cell recovery after experimental T-cell-depleted bone marrow transplantation in T-cell- deficient mice by strong expansion of recent thymic emigrants. Blood 2003; 102: 1534-1540.
40. Zheng XX, Sanchez-Fueyo A, Sho M, Domenig C, Sayegh MH, Strom TB. Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity 2003; 19: 503-514.
41. Qin S, Cobbold S, Pope H et al. "Infectious" transplantation tolerance. Science 1993; 259: 974-977.
42. Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002; 195: 1641-1646.
43. Hara M, Kingsley CI, Niimi M et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001; 166: 3789-3796.
44. Kingsley CI, Karim M, Bushell AR, Wood KJ. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002; 168: 1080-1086.
45. Zhang ZX, Yang L, Young KJ, DuTemple B, Zhang L. Identification of a previously unknown antigen-specific regulatory T cells and its mechanism of suppression. Nat Med 2000; 6: 782-789.
46. Fu S, Yopp AC, Mao X et al. CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential. Am J Transplant 2004; 4: 65-78.
47. Li Y, Li XC, Zheng XX, Wells AD, Turka LA, Strom TB. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral tolerance. Nat Med 1999; 5: 1298-1302.
48. Dai Z, Lakkis FG. Cutting edge: Secondary lymphoid organs are essential for maintaining the CD4, but not CD8, naive T cell pool. J Immunol 2001; 167: 6711-6715.
49. Homann D, Teyton L, Oldstone MBA. Differential regulation of antiviral T-cell immunity results in stable CD8 but declining CD4 T-cell memory. Nat Med 2001; 7: 913-919.
50. Wang J, Guo Z, Dong Y et al. Role of 4-1BB in allograft rejection mediated by CD8+ T cells. Am J Transplant 2003; 3: 543-551.
51. Zhang Q, Chen Y, Fairchild RL, Heeger PS, Valujskikh A. Lymphoid sequestration of alloreactive memory CD4 T cells promotes cardiac allograft survival. J Immunol 2006; 176: 770-777.